These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32312777)

  • 41. Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials.
    Sandison T; De Anda C; Fang E; Das AF; Prokocimer P
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of Translational Pharmacokinetic/Pharmacodynamic Infection Models To Understand the Impact of Neutropenia on the Efficacy of Tedizolid Phosphate.
    Xiao J; Gill C; Liang L; Liu J; Wu J; Feng HP; Flanagan S; Tan C; Flattery A
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.
    Ferrández O; Urbina O; Grau S
    Drug Des Devel Ther; 2017; 11():65-82. PubMed ID: 28053508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections.
    Bradley JS; Antadze T; Ninov B; Tayob MS; Broyde N; Butterton JR; Chou MZ; De Anda CS; Kim JY; Sears PS
    Pediatr Infect Dis J; 2021 Mar; 40(3):238-244. PubMed ID: 33395210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of tedizolid and linezolid against Staphylococcus epidermidis isolated from prosthetic joint infections.
    Littorin C; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
    Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1549-1552. PubMed ID: 28326447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term use of tedizolid for pulmonary nocardiosis.
    Chomei Y; Nishimura S; Iwata K
    J Infect Chemother; 2022 Aug; 28(8):1172-1176. PubMed ID: 35450784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections.
    Delpech P; ALeryan M; Jones B; Gemmell C; Lang S
    Diagn Microbiol Infect Dis; 2018 May; 91(1):93-97. PubMed ID: 29452993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis.
    Lan SH; Lin WT; Chang SP; Lu LC; Chao CM; Lai CC; Wang JH
    Antibiotics (Basel); 2019 Sep; 8(3):. PubMed ID: 31487837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Target Therapeutic Ranges of Anti-MRSA Drugs, Linezolid, Tedizolid and Daptomycin, and the Necessity of TDM.
    Matsumoto K; Samura M; Tashiro S; Shishido S; Saiki R; Takemura W; Misawa K; Liu X; Enoki Y; Taguchi K
    Biol Pharm Bull; 2022; 45(7):824-833. PubMed ID: 35786589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tedizolid: A New Oxazolidinone Antibiotic for Skin and Soft Tissue Infections.
    Chahine EB; Sucher AJ; Knutsen SD
    Consult Pharm; 2015 Jul; 30(7):386-94. PubMed ID: 26173190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016.
    Karlowsky JA; Hackel MA; Bouchillon SK; Alder J; Sahm DF
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):151-157. PubMed ID: 28793964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and tolerability of linezolid in children.
    Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Brown-Elliott BA; Wallace RJ
    J Clin Microbiol; 2017 Jun; 55(6):1747-1754. PubMed ID: 28330892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tedizolid for the management of human infections: in vitro characteristics.
    Locke JB; Zurenko GE; Shaw KJ; Bartizal K
    Clin Infect Dis; 2014 Jan; 58 Suppl 1():S35-42. PubMed ID: 24343830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014.
    Pfaller MA; Flamm RK; Jones RN; Farrell DJ; Mendes RE
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5393-9. PubMed ID: 27353270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
    Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pharmacological action and clinical effect of tedizolid phosphate (SIVEXTRO
    Mori M; Takase A
    Nihon Yakurigaku Zasshi; 2020; 155(5):332-339. PubMed ID: 32879176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
    Kidd JM; Abdelraouf K; Nicolau DP
    J Antimicrob Chemother; 2019 Apr; 74(4):970-977. PubMed ID: 30561650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correction of thrombocytopenia caused by linezolid with scheduled sequential tedizolid use in patients with vertebral osteomyelitis by antibiotic resistant Gram-positive organisms.
    Ueda T; Nakajima K; Ichiki K; Ishikawa K; Yamada K; Tsuchida T; Otani N; Takahashi Y; Ishihara M; Takubo S; Iijima K; Ikeuchi H; Uchino M; Kimura T; Takesue Y
    J Infect Chemother; 2022 Jul; 28(7):1023-1028. PubMed ID: 35477667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents.
    Bradley JS; Flanagan SD; Arrieta AC; Jacobs R; Capparelli E; Prokocimer P
    Pediatr Infect Dis J; 2016 Jun; 35(6):628-33. PubMed ID: 26910588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.